Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of GNI Group Ltd.. A complete text table follows the diagram.
Medical devices grew 57%, but weaker Etuary sales, Cullgen listing costs and clinical spending pushed operating loss to JPY1.18B.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Pharmaceutical | 1 | 8.2B | 66.9% of reported total |
| Medical device | 1 | 4.1B | 33.1% of reported total |
| External customer revenue | 2 | 12.3B | Reported six-month total · ¥12.3B |
| Operating loss | 2 | 1.2B | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 13.4B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Pharmaceutical | External customer revenue | 8.2B |
| Medical device | External customer revenue | 4.1B |
| External customer revenue | Operating costs & expenses | 12.3B |
| Operating loss | Operating costs & expenses | 1.2B |